Location History:
- Andhra Pradesh, IN (2018)
- Telangana, IN (2020 - 2022)
Company Filing History:
Years Active: 2018-2022
Title: Brahmaiah Dabbugoddu: Innovator in CaMKII Inhibitors
Introduction
Brahmaiah Dabbugoddu is a notable inventor based in Telangana, India. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit Ca/calmodulin-dependent protein kinase (CaMKII). With a total of 3 patents to his name, his work has the potential to impact various therapeutic applications.
Latest Patents
Dabbugoddu's latest patents focus on CaMKII inhibitors and their uses. The present invention provides compounds that are useful as inhibitors of CaMKII, along with compositions and methods for utilizing these compounds effectively. This innovation is crucial for advancing research in related medical fields.
Career Highlights
Throughout his career, Brahmaiah Dabbugoddu has worked with prestigious organizations, including The Johns Hopkins University and Allosteros Therapeutics, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Daniel Emil Levy and Howard Schulman. Their collaboration has likely enriched the research environment and fostered innovative ideas in the realm of biochemistry.
Conclusion
Brahmaiah Dabbugoddu's contributions to the development of CaMKII inhibitors highlight his role as an influential inventor in the field of biochemistry. His work continues to pave the way for advancements in therapeutic applications.